Search results

The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.

ANSTO sets out the following terms and conditions relating to users who access our facilities for the purpose of research.

An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.

Four international authorities will deliver plenary addresses virtually at the 15th International Conference on Accelerator Mass Spectrometry (AMS15) , which will be held online from 15-19 November.

ANSTO’s Innovation Precinct has been highlighted in the Greater Sydney Commission’s South District Plan.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Modified component of green tea promises potential neuroblastoma treatment.

Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.

Lutetium-177 used for advanced prostate cancer

ANSTO is home to over AUD$1.3B state of the art instruments and science technology. To access ANSTO’s world-leading and highly specialised facilities and capabilities, please contact our Industry Engagement team. This way we can co-ordinate your enquiry and provide advice on your application.

Work with our scientists to deliver the best possible decommissioning outcome for your organisation.

Wolfgang Kubicki, MdB and a small delegation visited to see the Spatz neutron instrument donated by Helmholtz Zentrum  Berlin (HZB) and discuss research.

Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.

Specifications, Instrument layout, and Instrument reference